A Successful Debut at LEAP East Hong Kong

COI was proud to participate in LEAP East 2026, marking the highly anticipated debut of the globally renowned technology conference in Hong Kong. Bringing together innovators, researchers, entrepreneurs, investors, and industry leaders from around the world, LEAP East provided a dynamic platform for exploring the technologies shaping the future.

At our booth, we showcased Prof. Alan Wong's pioneering research on next-generation gene editing tools, including the CombiSEAL and TopVIP platforms, which are designed to enhance the precision, efficiency, and safety of CRISPR-based gene editing by minimizing unintended genetic effects.

Throughout the 3 days, we had the opportunity to engage with researchers, industry professionals, investors, and members of the public who were eager to learn more about the potential of advanced gene-editing technologies. The discussions reinforced the growing importance of biotechnology innovation in addressing future healthcare challenges and advancing precision medicine.

We thank everyone who visited us and look forward to fostering new collaborations that advance the future of biotechnology and healthcare.

Stay updated on COI’s latest news and breakthroughs by following us on our social media platforms and visiting our website. Together, we can make a difference in the lives of those affected by cancer.